Kraig Biocraft Laboratories, Inc. – ‘S-1/A’ on 12/3/21 – ‘EXCEL’

On:  Friday, 12/3/21, at 4:32pm ET   ·   Accession #:  1493152-21-30443   ·   File #:  333-238883

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Pre-Effective Amendment to Registration Statement (General Form)   —   Form S-1   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML   3.18M 
                (General Form)                                                   
 2: EX-23.1     Consent of Expert or Counsel                        HTML     19K 
 9: R1          Cover                                               HTML     46K 
10: R2          Condensed Consolidated Balance Sheets               HTML    130K 
11: R3          Condensed Consolidated Balance Sheets               HTML     46K 
                (Parenthetical)                                                  
12: R4          Condensed Consolidated Statements of Operations     HTML     87K 
                (Unaudited)                                                      
13: R5          Condensed Consolidated Statement of Changes in      HTML    106K 
                Stockholders Deficit (Unaudited)                                 
14: R6          Condensed Consolidated Statement of Changes in      HTML     24K 
                Stockholders Deficit (Unaudited) (Parenthetical)                 
15: R7          Condensed Consolidated Statements of Cash Flows     HTML    134K 
                (Unaudited)                                                      
16: R8          Summary of Significant Accounting Policies and      HTML    185K 
                Organization                                                     
17: R9          Going Concern                                       HTML     26K 
18: R10         Equipment                                           HTML     49K 
19: R11         Right to Use Assets and Lease Liabilitity           HTML     78K 
20: R12         Accrued Interest - Related Party                    HTML     43K 
21: R13         Note Payable                                        HTML     43K 
22: R14         Convertible Notes                                   HTML    125K 
23: R15         Stockholders? Deficit                               HTML    506K 
24: R16         Commitments and Contingencies                       HTML    147K 
25: R17         Related Party Transactions                          HTML    121K 
26: R18         Subsequent Events                                   HTML     34K 
27: R19         Summary of Significant Accounting Policies and      HTML    224K 
                Organization (Policies)                                          
28: R20         Summary of Significant Accounting Policies and      HTML    107K 
                Organization (Tables)                                            
29: R21         Equipment (Tables)                                  HTML     43K 
30: R22         Right to Use Assets and Lease Liabilitity (Tables)  HTML     51K 
31: R23         Convertible Notes (Tables)                          HTML     77K 
32: R24         Stockholders? Deficit (Tables)                      HTML    373K 
33: R25         Schedule of Antidilutive Securities of Earnings     HTML     32K 
                Per Share (Details)                                              
34: R26         Schedule of Antidilutive Securities of Earnings     HTML     25K 
                Per Share (Details) (Parenthetical)                              
35: R27         Schedule of Fair Value of Financial Instruments     HTML     27K 
                (Details)                                                        
36: R28         Schedule of Gold in Bullion (Details)               HTML     36K 
37: R29         Summary of Significant Accounting Policies and      HTML     40K 
                Organization (Details Narrative)                                 
38: R30         Going Concern (Details Narrative)                   HTML     29K 
39: R31         Schedule of Property and Equipment (Details)        HTML     36K 
40: R32         Equipment (Details Narrative)                       HTML     24K 
41: R33         Schedule of Right Use of Assets (Details)           HTML     29K 
42: R34         Schedule of Lease Liability (Details)               HTML     37K 
43: R35         Schedule of Lease Cost (Details)                    HTML     27K 
44: R36         Right to Use Assets and Lease Liabilitity (Details  HTML     81K 
                Narrative)                                                       
45: R37         Accrued Interest - Related Party (Details           HTML     48K 
                Narrative)                                                       
46: R38         Note Payable (Details Narrative)                    HTML     74K 
47: R39         Schedule of Fair Value Warrants (Details)           HTML     45K 
48: R40         Summary of Convertible Debt (Details)               HTML     49K 
49: R41         Convertible Notes (Details Narrative)               HTML    101K 
50: R42         Schedule of Option Assumption (Details)             HTML    105K 
51: R43         Schedule of Warrants Activity (Details)             HTML     46K 
52: R44         Schedule of Warrants Outstanding (Details)          HTML     72K 
53: R45         Schedule of Options Outstanding (Details)           HTML     28K 
54: R46         Stockholders? Deficit (Details Narrative)           HTML    509K 
55: R47         Commitments and Contingencies (Details Narrative)   HTML    600K 
56: R48         Related Party Transactions (Details Narrative)      HTML    445K 
57: R49         Subsequent Events (Details Narrative)               HTML     69K 
58: R50         Schedule of Deferred Tax Assets and Liabilities     HTML     30K 
                (Details)                                                        
59: R51         Schedule of Deferred Tax Assets and Liabilities     HTML     20K 
                (Details) (Parenthetical)                                        
60: R52         Schedule of Components Deferred Income Taxes        HTML     27K 
                (Details)                                                        
62: XML         IDEA XML File -- Filing Summary                      XML    115K 
 8: XML         XBRL Instance -- forms-1a_htm                        XML   3.61M 
61: EXCEL       IDEA Workbook of Financial Reports                  XLSX    108K 
 4: EX-101.CAL  XBRL Calculations -- kblb-20210930_cal               XML    143K 
 5: EX-101.DEF  XBRL Definitions -- kblb-20210930_def                XML    739K 
 6: EX-101.LAB  XBRL Labels -- kblb-20210930_lab                     XML   1.28M 
 7: EX-101.PRE  XBRL Presentations -- kblb-20210930_pre              XML    973K 
 3: EX-101.SCH  XBRL Schema -- kblb-20210930                         XSD    207K 
63: JSON        XBRL Instance as JSON Data -- MetaLinks              371±   495K 
64: ZIP         XBRL Zipped Folder -- 0001493152-21-030443-xbrl      Zip    451K 

‘EXCEL’   —   IDEA Workbook of Financial Reports

This is an IDEA Workbook.

Download this Microsoft® Excel® .xlsx workbook

15 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/26/21  Kraig Biocraft Laboratories, Inc. 8-K:1,3,8,9 1/26/21    4:217K                                   M2 Compliance LLC/FA
12/11/20  Kraig Biocraft Laboratories, Inc. 8-K:1,2,8,912/11/20    5:541K                                   M2 Compliance LLC/FA
 6/02/20  Kraig Biocraft Laboratories, Inc. S-1                   71:7.9M                                   M2 Compliance LLC/FA
 3/27/20  Kraig Biocraft Laboratories, Inc. 10-K       12/31/19   62:4.6M                                   M2 Compliance LLC/FA
 3/31/15  Kraig Biocraft Laboratories, Inc. 10-K       12/31/14   50:4.1M                                   Issuer Direct/FA
 1/30/15  Kraig Biocraft Laboratories, Inc. S-1/A                  6:5.4M                                   Issuer Direct/FA
 1/21/15  Kraig Biocraft Laboratories, Inc. 8-K:5,7,9   1/20/15    3:98K                                    Issuer Direct/FA
12/19/13  Kraig Biocraft Laboratories, Inc. 8-K:3,5,9  12/17/13    2:901K                                   Issuer Direct/FA
11/22/13  Kraig Biocraft Laboratories, Inc. 8-K:5,9    11/15/13    2:678K                                   Issuer Direct/FA
 8/01/11  Kraig Biocraft Laboratories, Inc. S-1                    4:3.4M                                   EdgarAgents LLC/FA
 4/15/10  Kraig Biocraft Laboratories, Inc. 10-K       12/31/09    5:1.5M                                   EdgarAgents LLC/FA
 1/25/10  Kraig Biocraft Laboratories, Inc. S-1/A                  3:2.5M                                   EdgarAgents LLC/FA
10/02/09  Kraig Biocraft Laboratories, Inc. S-1                    4:2.3M                                   EdgarAgents LLC/FA
 3/26/08  Kraig Biocraft Laboratories, Inc. 10KSB      12/31/07    4:881K                                   EdgarAgents LLC/FA
 9/26/07  Kraig Biocraft Laboratories, Inc. SB-2                   9:1.7M                                   EdgarAgents LLC/FA